Biosynthetically, the phragmalin-type limonoids likely
arise from the related mexicanolide-type natural products
(e.g., 7, Scheme 1). A possible biogenetic connection
between the mexicanolide-type (7) and corresponding
phragmalin derivatives (e.g., 9), proposed by Hao and
co-workers,7 is outlined in Scheme 1. This process may
begin with a photoinitiated Norrish type II reaction to
afford the strained octahydro-1H-2,4-methanoindene frame-
work. Given that the Norrish type II product (9) likely
represents the photostationary state, highly strained sys-
tems of this type may be accessed.
skeleton was to apply the method of network analysis.9
To forge the caged methanoindene polycycle (see 6 in
Figure 1), a disconnection of any of the bonds shown
in red would realize the main goal of network analysis,
namely, the simplification of the complex caged structure
to a fused ring system.8b Despite the powerful reduction in
complexity in the retrosynthetic sense that this approach
offers, we were cognizant of the significant challenge that
the forward CÀC bond construction posed due to the
accompanying increase in strain.10
In this communication, we report the successful imple-
mentation of network analysis guidelines for forming
functionalized octahydro-1H-2,4-methanoindene frame-
works (14 and 26, Scheme 2 and 6, respectively), which
serve as models for the challenging phragmalin-type caged
architecture (e.g., in xyloccensin O, 2).
Scheme 1. Proposed Biogenetic Connection between Mexica-
nolide-Type and Phragmalin-Type Limonoids
Initial studies focused on the construction of 14. This
undertaking would demonstrate the feasibility of the in-
tramolecular cylization by using an irreversible alkylation
before attempting the bond construction using a
potentially reversible Michael addition (vide infra). We
envisioned that 14 could arise from conformer 13A of
hydrindanone derivative 13 by an alkylative CÀC bond
formation. Although conformations of hydrindane and
hydrindanone systems have been studied,11 there are no
reports that describe these dynamics in highly functiona-
lized systems. Despite preliminary computations suggest-
ing conformer 13B to be lower in energy, the irreversibility
of the alkylation step arising from conformer 13A was
expected to lead to productive formation of 14.12 Hydrin-
danone derivative 13 could in turn arise from a
DielsÀAlder cycloaddition between cyclopentenone 11
and diene 12.
Biomimetic syntheses can often bring an unprecedented
level of simplication to a challenging synthetic target;8
however, the unique environ of an enzyme, should one
be required, is not easily emulated by synthetic chemists.
For the phragmalin-type limonoids in particular, the strict
conformational requirements regarding the proximity of
reacting partners in photoreactions, including the Norrish
type II process, makes it unclear how high yielding the
conversion of 7 to 9 would be outside of a biological
context. As such, we decided to pursue alternative, more
robust, strategies for the formation of the caged phragma-
lin framework.
Given that 2-methoxycarbonylcyclopent-2-enone (11) is
readily available in multigram quantities,13 our synthesis of
13 commenced with the preparation of diene 12 (Scheme 3).
(9) (a) Corey, E. J.; Ohno, M.; Vatakencherry, P. A.; Mitra, R. B. J.
Am. Chem. Soc. 1961, 83, 1251–1253. (b) Corey, E. J.; Ohno, M.; Mitra,
R. B.; Vatakencherry, P. A. J. Am. Chem. Soc. 1964, 86, 478–485. (c)
Corey, E. J.; Howe, W. J.; Orf, H. W.; Pensak, D. A.; Petersson, P. G. J.
Am. Chem. Soc. 1975, 97, 6116–6124. (d) Corey, E. J. Angew. Chem., Int.
Ed. 1991, 30, 455–465.
(10) For example, the following homodesmotic calculation
(Gaussian DFT; basis set B3LYP/6-31G(d,p); see the Supporting In-
formation for details) indicates that formation of the tricycle from the
bicycle is uphill by 10.36 kcal/mol. For a discussion on homodesmotic
calculations, see: Wheeler, S. E.; Houk, K. N.; Schleyer, P. v. R.; Allen,
W. D. J. Am. Chem. Soc. 2009, 131, 2547–2560.
Foremost among our considerations as to how to access
the architecturally intricate phragmalin-type tricyclic
(5) (a) Ravangpai, W.; Sommit, D.; Teerawatananond, T.; Sinpranee,
N.; Palaga, T.; Pengpreecha, S.; Muangsin, N.; Pudhom, K. Bioorg. Med.
Chem. Lett. 2011, 21, 4485–4489. (b) Luo, J.; Wang, J.-S.; Luo, J.-G.;
Wang, X.-B.; Kong, L.-Y. Tetrahedron 2011, 67, 2942–2948.
(6) Wu, J.; Xiao, Q.; Zhang, S.; Li, X.; Xiao, Z.; Ding, H.; Li, Q.
Tetrahedron 2005, 61, 8382–8389.
(7) Zhang, Q.; Di, Y.-T.; He, H.-P.; Fang, X.; Chen, D.-L.; Yan,
X.-H.; Zhu, F.; Yang, T.-Q.; Liu, L.-L.; Hao, X.-J. J. Nat. Prod. 2011, 74,
152–157. For other proposed biosynthetic pathways for more highly
oxygenated limonoids, see: (a) Taylor, D. A. H. Phytochemistry 1983, 22,
1297–1299. (b) Abdelgaleil, S. A. M.; Okamura, H.; Iwagawa, T.; Sato, A.;
Miyahara, I.; Doe, M.; Nakatani, M. Tetrahedron 2001, 57, 119–126.
(8) (a) Nicolaou, K. C.; Montagnon, T.; Snyder, S. A. Chem. Com-
mun. 2003, 551–564. (b) Heathcock, C. H. Angew. Chem., Int. Ed. 1992,
31, 665–681.
(11) (a) Sokolova, I. M.; Petrov, A. A. Neftekhimiya 1977, 17, 498;
Chem. Abstr. 87, 184059b. (b) Lo cicero, B.; Weisbuch, F.; Dana, G. J.
Org. Chem. 1981, 46, 914–919. (c) Schneider, H.-J.; Nguyen-Ba, N. Org.
Magn. Reson. 1982, 18, 38. (d) Moniz, W. B.; Dixon, J. A. J. Am. Chem.
Soc. 1961, 83, 1671–1675. (e) Lack, R. E.; Roberts, J. D. J. Am. Chem.
Soc. 1968, 90, 6997–7001.
(12) Our preliminary conformational search of 13 using Macromodel
minimization/Monte Carlo search parameters has identified compound
13B as more energetically stable than compound 13A.
(13) Wang, C.; Gu, X.; Yu, M. S.; Curran, D. P. Tetrahedron 1998,
54, 8355–8370.
Org. Lett., Vol. 14, No. 8, 2012
2111